AMG

#948
Affiliated Managers Group, Inc. Common Stock
360.7 5 USD
-0.02%
Market Price
Settore: Finanziario
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
360.51
364.35
Intervallo Annuale
227.21
392.92
Variazione giornaliera
-2.02%
Variazione Mensile
-3.89%
Variazione di 6 mesi
+18.78%
Variazione Annuale
+57.97%
Chiusura Precedente
368.1 8
Open
364.3 5
Minimo
360.5 1
Massimo
364.3 5
Volume
214
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche Dividendi Documents

2026

Current report, Q3 FY2026
AFFILIATED MANAGERS GROUP, INC. current report, Q3 FY2026
8-K
Quarterly report, Q2 FY2026
AFFILIATED MANAGERS GROUP, INC. quarterly report, Q2 FY2026
10-Q
Current report, Q2 FY2026
AFFILIATED MANAGERS GROUP, INC. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
AFFILIATED MANAGERS GROUP, INC. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
AFFILIATED MANAGERS GROUP, INC. current report, Q2 FY2026
8-K
Quarterly report, Q1 FY2026
AFFILIATED MANAGERS GROUP, INC. quarterly report, Q1 FY2026
10-Q
Current report, Q1 FY2026
AFFILIATED MANAGERS GROUP, INC. current report, Q1 FY2026
8-K
Current report, Q1 FY2026
AFFILIATED MANAGERS GROUP, INC. current report, Q1 FY2026
8-K
Current report, Q1 FY2026
AFFILIATED MANAGERS GROUP, INC. current report, Q1 FY2026
8-K

2025

Annual report, FY2025
AFFILIATED MANAGERS GROUP, INC. annual report, FY2025
10-K

AFFILIATED MANAGERS GROUP, INC. current report, Q2 FY2018

Full document

Business Context and Reporting Period

This Form 8-K Current Report was filed by Affiliated Managers Group, Inc. on May 25, 2018, with the earliest event reported on May 29, 2018. The filing primarily addresses significant changes in executive leadership and corporate governance.

Key Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on corporate events rather than financial performance data.

Material Changes

  • Executive Leadership Transition: Nathaniel Dalton succeeded Sean M. Healey as Chief Executive Officer, effective immediately on May 29, 2018. Mr. Dalton was previously the President and Chief Operating Officer.
  • Board Appointment: Nathaniel Dalton was appointed to the Company's Board of Directors.
  • Role Change for Outgoing CEO: Sean M. Healey assumed the role of Executive Chairman, effective immediately.
  • Reason for Transition: Mr. Healey has been diagnosed with amyotrophic lateral sclerosis (ALS) and will pursue treatment while remaining active in strategy execution.
  • Annual Meeting Location Change: The location of the June 12, 2018 Annual Meeting of Stockholders was changed to the Company's office at 600 Hale Street, Prides Crossing, Massachusetts.

Guidance, Outlook, and Risks

The filing does not contain updated financial guidance or outlook. Management commentary indicates that Mr. Healey will continue to play an active role in the execution of the Company's strategy despite his health condition. The primary risk disclosed relates to the sudden leadership transition due to the CEO's medical diagnosis.

Investor Verification Checklist

  • Verify the transition timeline and specific responsibilities of the new CEO, Nathaniel Dalton.
  • Confirm the extent of Sean M. Healey's continued involvement as Executive Chairman.
  • Review the updated Proxy Statement supplement regarding the new location for the June 12, 2018 Annual Meeting.
  • Check for any subsequent press releases or filings detailing the long-term succession plan or strategic shifts.

Notizie